Polypeptide compound taking PD-1 receptor as target point as well as preparation method and application thereof
A technology of PD-1 and peptide compounds, which is applied in the field of peptide compounds, can solve problems such as hindering applications, and achieve the effects of easy purification, improved pharmacokinetic properties, and simple synthesis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] Example 1 Solid phase synthesis of Compound 1 ~ 5
[0038] The synthesis of the compounds 1 to 5 of the present invention employs a FMOC-solid phase synthesis method, and the solid phase carrier is WANG-resin. The release reagent of the amino protecting group 9-fluorenoxycarbonyl (FMOC) is 20% hexapyridine N, N-dimethylformamide solution. The peptide chain extension desired condensation reagent is N, N-diisopropyl ethylamine / 1-hydroxybenzene triazole / O-benzotriazole-tetramethylurea hexafluorophosphate, the required amount of resin used The amount of material is 3 to 6 times. The crude peptide cuts from the resin to a mixture of trifluoroacetic acid / triisopropylsilane / double vapor solution of 95: 2.5: 2.5. The composition and ratio of the condensation reagent, the FMOC removal reagent, the fmoC removal reagent, the indanjense reagent is known to those skilled in the art.
[0039] 1) Synthesis of Compound 1
[0040]Weigh WANG resin, dichloromethane swelling, methyl me...
Embodiment 2D
[0059] Example 2DRG neuron calcium imaging experiment
[0060] The suppression effect of the compound 1 to 5 on the pain signal conduction by DRG neuronal calcium imaging technique, specifically includes the steps of:
[0061] 3 weeks of female ICR mice were extracted by acute separation, with a sterile console to extract DRG, collagenase A, and trigrase sequentially. Complete medium containing serum terminates the pancreatic enzyme cleavage, 800R centrifugation, abandoned, add NEUROBASAL medium (including 2% B27, Clutanine 1%, and 1% penicillin-streptomycin dual anti-solution), after average Culture 48 h in a versa of PDL. After the experiment, FLOU-4 / AM label DRG neurons were used. After pretreatment of different doses 1 to 5 / or the like, the high K + solution stimulated DRG neurons, and the laser co-focus was detected by the DRG neuron cell free calcium ion concentration. The change.
[0062] Experimental results of calcium imaging figure 2 As shown: Compound 4 pretreatment...
Embodiment 3
[0063] Example 3 Formallin - induced inflammatory pain experiment
[0064] The present invention selects an ICR male mole having a weight range of 25-30 g, and is placed in an observation chamber to accommodate 15 min, injection of different doses of compound 4 (5 nmol, 10 nmol, 30 nmol) or physiological saline, 5 minutes after 5 minutes. The formalin solution (20 μL) was immediately placed in the observation chamber, and the accumulation time of the pain behavior (licking, bite, injection) in the period of 0-10 min, 10-45min period, respectively.
[0065] In the pain model induced by Holmalin, after the mouse was subcutaneously injected with formalin, mice showed pain, bite, claw and telescopic legs. The injection of the formalin was 0-10min for I phase, mainly caused by direct activation of injury neurons; 10-35min is II phase, mainly caused by formalin induced inflammatory responses. Experimental results image 3 As shown, Compound 4 significantly shortens the pain behavior of t...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com